Terns Pharmaceuticals, Inc. (TERN) Social Stream



Terns Pharmaceuticals, Inc. (TERN): $9.42

0.01 (+0.11%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

TERNS PHARMACEUTICALS INC (TERN) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering TERNS PHARMACEUTICALS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-22 1 $19 $19 $19 $8.1 134.57%
2022-03-07 2 $19 $19 $19 $8.1 134.57%
2022-05-18 2 $6 $6 $6 $8.1 -25.93%
2022-08-10 2 $5 $5 $5 $8.1 -38.27%
2022-09-12 3 $6 $5 $5.5 $8.1 -32.1%
2022-11-11 4 $9 $5 $6.666 $8.1 -17.7%
2022-11-21 4 $9 $6 $7 $8.1 -13.58%
2022-12-20 4 $14 $6 $8.666 $8.1 6.99%
2022-12-29 4 $14 $6 $9 $8.1 11.11%

The Trend in the Analyst Price Target


TERN's average price target has moved down $20 over the prior 22 months.

Over the past 42 weeks, TERN's average upside potential has been 98.13%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-18 2 6 6 6.000 1.61 272.67%
2022-09-28 4 9 5 6.666 5.60 19.04%
2022-11-11 4 9 5 6.666 4.95 34.67%
2022-11-21 4 9 6 7.000 5.44 28.68%
2022-12-29 4 14 6 9.000 9.51 -5.36%

TERN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 2 0 2 0 0 4

The Trend in the Broker Recommendations


TERN's average broker recommendation rating improved by 0 over the prior 31 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TERN as an investment opportunity.

  • In the context of all US stocks, TERNS PHARMACEUTICALS INC's average analyst price target is higher than 93.54% of them.
  • TERNS PHARMACEUTICALS INC's number of analysts covering the stock is greater than 99.08% of all US stocks.
  • In the context of all US stocks, TERNS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 222.8% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, TERNS PHARMACEUTICALS INC's variance in analysts' estimates is lower than -123.15% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to TERNS PHARMACEUTICALS INC are SNSE, PHVS, and ADAG.

Is TERN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7637 seconds.